PAR-21-133 - First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest: NIMH Priorities on Research on Aggression and Violence Against Others | NOT-MH-22-095 | NIMH | Feb 3, 2022 | Jan 8, 2025 | R36, R01, R34, R21, F32, R21/R33, R03, R61/R33, U01, K08, R15, K23, P50, F30, K99/R00, F31, K22, K01 |
| Notice of Special Interest: NIMHs Interest in Early Stage Clinical and/or Mechanistic Trials in Posttraumatic Psychopathology, Directed at Testing FAAH Inhibitors | NOT-MH-19-055 | NIMH | Oct 17, 2019 | Jan 8, 2022 | U01, R61/R33, R21, R01 |

